Mark Borodkin
Keine laufenden Positionen mehr
Vermögen: 241 242 $ am 30.04.2024
Profil
Mark Borodkin worked as a Chief Product Officer & Engineering Director at Azenta, Inc. He was an Engineering Director at Affymetrix, Inc. from 2009 to 2011.
He worked as a Senior Manager at Siemens Healthcare Diagnostics, Inc. from 2007 to 2009.
He was a Senior Manager-Engineering at Applied Biosystems, Inc. He also worked as a Vice President-Systems Development at Bionano Genomics, Inc. from 2014 to 2017.
Mr. Borodkin received his undergraduate degree in 1995 and his graduate degree in 2004 from Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0,52% | 18.09.2023 | 317 842 ( 0,52% ) | 241 242 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Mark Borodkin
| Unternehmen | Position | Ende |
|---|---|---|
| AFFYMETRIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2011 |
Siemens Healthcare Diagnostics, Inc.
 Siemens Healthcare Diagnostics, Inc. Medical/Nursing ServicesHealth Services Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY. | Corporate Officer/Principal | 01.04.2009 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Technik-/Wissenschafts-/F&E-Leiter | - |
| AZENTA, INC. | Corporate Officer/Principal | - |
| BIONANO GENOMICS, INC. | Geschäftsführer | - |
Ausbildung von Mark Borodkin
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| AZENTA, INC. | Health Services |
| Private Unternehmen | 3 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Siemens Healthcare Diagnostics, Inc.
Siemens Healthcare Diagnostics, Inc. Medical/Nursing ServicesHealth Services Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY. | Health Services |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
